Development of chimeric antigen receptor (CAR) T-cell immunotherapy for glioblastoma targeting epidermal growth factor receptor variant III (EGFRvIII)

Ítems similars

• Smart CARS: optimized development of a chimeric antigen receptor (CAR) T cell targeting epidermal growth factor receptor variant III (EGFRvIII) for glioblastoma
  per: Ruella, Marco, et al.
  Publicat: (2016)
• IMCT-15 PILOT STUDY OF T CELLS REDIRECTED TO EGFRvIII WITH A CHIMERIC ANTIGEN RECEPTOR IN PATIENTS WITH EGFRvIII+ GLIOBLASTOMA
  per: O'Rourke, Donald, et al.
  Publicat: (2015)
• The evolution of the EGFRvIII (rindopepimut) immunotherapy for glioblastoma multiforme patients
  per: Paff, Michelle, et al.
  Publicat: (2015)
• Anti-EGFRvIII Chimeric Antigen Receptor-Modified T Cells for Adoptive Cell Therapy of Glioblastoma
  per: Ren, Pei-pei, et al.
  Publicat: (2017)
• NIMG-05 IDENTIFICATION OF IMAGING SIGNATURES OF THE EPIDERMAL GROWTH FACTOR RECEPTOR VARIANT III (EGFRvIII) IN GLIOBLASTOMA
  per: Bakas, Spyridon, et al.
  Publicat: (2015)